These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33395778)

  • 1. The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
    Lukito AA; Pranata R; Henrina J; Lim MA; Lawrensia S; Suastika K
    Diabetes Metab Syndr; 2020; 14(6):2177-2183. PubMed ID: 33395778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
    Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
    Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.
    Han T; Ma S; Sun C; Zhang H; Qu G; Chen Y; Cheng C; Chen EL; Ayaz Ahmed M; Kim KY; Manem R; Chen M; Guo Z; Yang H; Yan Y; Zhou Q
    Arch Med Res; 2022 Feb; 53(2):186-195. PubMed ID: 34412904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
    Singh AK; Singh R; Saboo B; Misra A
    Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
    Scheen AJ
    Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.
    Ganesh A; Randall MD
    Br J Clin Pharmacol; 2022 Jun; 88(6):2642-2656. PubMed ID: 35122284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study.
    Bramante CT; Johnson SG; Garcia V; Evans MD; Harper J; Wilkins KJ; Huling JD; Mehta H; Alexander C; Tronieri J; Hong S; Kahkoska A; Alamgir J; Koraishy F; Hartman K; Yang K; Abrahamsen T; Stürmer T; Buse JB;
    PLoS One; 2022; 17(11):e0271574. PubMed ID: 36395143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
    Lally MA; Tsoukas P; Halladay CW; O'Neill E; Gravenstein S; Rudolph JL
    J Am Med Dir Assoc; 2021 Jan; 22(1):193-198. PubMed ID: 33232684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):19-27. PubMed ID: 32860962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
    Usman A; Bliden KP; Cho A; Walia N; Jerjian C; Singh A; Kundan P; Duhan S; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2022 Feb; 53(2):363-371. PubMed ID: 35041121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.
    Kan C; Zhang Y; Han F; Xu Q; Ye T; Hou N; Sun X
    Front Endocrinol (Lausanne); 2021; 12():708494. PubMed ID: 34603199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.